AIMS: Percutaneous coronary interventions (PCI) are used to treat acute and chronic forms of coronary artery disease. While in chronic forms the main goal of PCI is to improve the quality of life, in acute coronary syndromes (ACS) timely PCI is a life-saving procedure - especially in the setting of ST-elevation myocardial infarction (STEMI). The aim of this study was to describe the experience of countries with successful nationwide implementation of PCI in STEMI, and to provide general recommendations for other countries. METHODS AND RESULTS: The European Association of Percutaneous Cardiovascular Interventions (EAPCI) recenty launched the Stent For Life Initiative (SFLI). The initial phase of this pan-European project was focused on the positive experience of five countries to provide the best practice examples. The Netherlands, the Czech Republic, Sweden, Denmark and Austria were visited and the logistics of ACS treatment was studied. Public campaigns improved patient access to acute PCI. Regional networks involving emergency medical services (EMS), non-PCI hospitals and PCI centres are useful in providing access to acute PCI for most patients. Direct transfer from the first medical contact site to the cathlab is essential to minimise the time delays. Cathlab staff work is organised to provide acute PCI services 24 hours a day / seven days a week (24/7). Even in those regions where thrombolysis is still used due to long transfer distances to PCI, patients should still be transferred to a PCI centre (after thrombolysis). The highest risk non-ST elevation acute myocardial infarction patients should undergo emergency coronary angiography within two hours of hospital admission, i.e. similar to STEMI patients. CONCLUSIONS: Three realistic goals for other countries were defined based on these experiences: 1) primary PCI should be used for >70% of all STEMI patients, 2) primary PCI rates should reach >600 per million inhabitants per year and 3) existing PCI centres should treat all their STEMI patients by primary PCI, i.e. should offer a 24/7 service.
AIMS: Percutaneous coronary interventions (PCI) are used to treat acute and chronic forms of coronary artery disease. While in chronic forms the main goal of PCI is to improve the quality of life, in acute coronary syndromes (ACS) timely PCI is a life-saving procedure - especially in the setting of ST-elevation myocardial infarction (STEMI). The aim of this study was to describe the experience of countries with successful nationwide implementation of PCI in STEMI, and to provide general recommendations for other countries. METHODS AND RESULTS: The European Association of Percutaneous Cardiovascular Interventions (EAPCI) recenty launched the Stent For Life Initiative (SFLI). The initial phase of this pan-European project was focused on the positive experience of five countries to provide the best practice examples. The Netherlands, the Czech Republic, Sweden, Denmark and Austria were visited and the logistics of ACS treatment was studied. Public campaigns improved patient access to acute PCI. Regional networks involving emergency medical services (EMS), non-PCI hospitals and PCI centres are useful in providing access to acute PCI for most patients. Direct transfer from the first medical contact site to the cathlab is essential to minimise the time delays. Cathlab staff work is organised to provide acute PCI services 24 hours a day / seven days a week (24/7). Even in those regions where thrombolysis is still used due to long transfer distances to PCI, patients should still be transferred to a PCI centre (after thrombolysis). The highest risk non-ST elevation acute myocardial infarctionpatients should undergo emergency coronary angiography within two hours of hospital admission, i.e. similar to STEMI patients. CONCLUSIONS: Three realistic goals for other countries were defined based on these experiences: 1) primary PCI should be used for >70% of all STEMI patients, 2) primary PCI rates should reach >600 per million inhabitants per year and 3) existing PCI centres should treat all their STEMI patients by primary PCI, i.e. should offer a 24/7 service.
Authors: Marc J Claeys; Peter R Sinnaeve; Carl Convens; Philippe Dubois; Jean Boland; Pascal Vranckx; Sofie Gevaert; Antoine de Meester; Patrick Coussement; Herbert De Raedt; Christophe Beauloye; Marc Renard; Christiaan Vrints; Patrick Evrard Journal: Eur Heart J Acute Cardiovasc Care Date: 2012-04
Authors: Mathew Mercuri; Michelle Welsford; Jon-David Schwalm; Shamir R Mehta; Purnima Rao-Melacini; Tej Sheth; Michael Rokoss; Sanjit S Jolly; James L Velianou; Madhu K Natarajan Journal: CMAJ Open Date: 2015-01-13
Authors: Rodrigo Estévez-Loureiro; Angela López-Sainz; Armando Pérez de Prado; Carlos Cuellas; Ramón Calviño Santos; Norberto Alonso-Orcajo; Jorge Salgado Fernández; Jose Manuel Vázquez-Rodríguez; Maria López-Benito; Felipe Fernández-Vázquez Journal: World J Cardiol Date: 2014-06-26
Authors: Gerald J Kost; Laurie E Kost; Audhaiwan Suwanyangyuen; Simrin K Cheema; Corbin Curtis; Stephanie Sumner; Jimmy Yu; Richard Louie Journal: Point Care Date: 2010-06
Authors: Shukri M Al-Saif; Khalid F Alhabib; Anhar Ullah; Ahmed Hersi; Husam Alfaleh; Khalid Alnemer; Amir Tarabin; Ahmed Abuosa; Tarek Kashour; Mushabab Al-Murayeh Journal: J Saudi Heart Assoc Date: 2011-10-19
Authors: A Lux; J Vainer; R A L J Theunissen; L F Veenstra; I Kasperski; B C G Gho; M Stein; M Ilhan; A W Ruiters; P J C Winkler; A van Beurden; W Dohmen; S Rasoul; A W J van 't Hof Journal: Neth Heart J Date: 2021-02-03 Impact factor: 2.380
Authors: Jacqueline Nuttall; Kerenza Hood; Theo Jm Verheij; Paul Little; Curt Brugman; Robert Er Veen; Herman Goossens; Christopher C Butler Journal: BMC Fam Pract Date: 2011-07-27 Impact factor: 2.497
Authors: Bernhard Jäger; Paul Michael Haller; Edita Piackova; Alfred Kaff; Günter Christ; Wolfgang Schreiber; Franz Weidinger; Thomas Stefenelli; Georg Delle-Karth; Gerhard Maurer; Kurt Huber Journal: Clin Res Cardiol Date: 2019-06-29 Impact factor: 5.460
Authors: Ander Regueiro; Julia Bosch; Victoria Martín-Yuste; Alba Rosas; Maria Teresa Faixedas; Joan Antoni Gómez-Hospital; Jaume Figueras; Antoni Curós; Angel Cequier; Javier Goicolea; Antonio Fernández-Ortiz; Carlos Macaya; Ricard Tresserras; Laura Pellisé; Manel Sabaté Journal: BMJ Open Date: 2015-12-09 Impact factor: 2.692